On October 22, Chief Administrative Law Judge Derek C. Julius turned down a request from three rescheduling opponents (DUID Victim Voices, Dr. Kenneth Finn and the National Drug and Alcohol Screening Association) to reopen the DEA's marijuana hearing for new testimony and document discovery. He did let a September Government Accountability Office report into the record, and he gave the parties a short window to argue about it. Optional briefs of up to 10 pages are due October 29, replies are due November 5, and the stay that has frozen the case since late September lifts on its own once that briefing closes.
The judge picked speed, and he was right to. The opponents wanted to reopen a record that already holds more than 2,500 pages of witness testimony and thousands of pages of exhibits, so they could add evidence about gaps in agency paperwork. That is a lot of hearing for a filing-cabinet problem.
What did the DEA judge decide on October 22?
Judge Julius denied the motion to reopen the rescheduling hearing for new testimony and discovery, admitted the GAO report on DEA and FDA scheduling procedures into the record, and allowed optional briefs of up to 10 pages on how much weight that report deserves. Briefs are due October 29 and replies November 5.
The order took the opponents' five discovery topics one at a time. Two were immaterial to the narrow question in front of the tribunal, two could have been raised when the opponents cross-examined the FDA's controlled substances staff director during the summer hearing, and the fifth would only muddy the record. The judge also pointed out that the government carries the burden of proof, so if the opponents think the record is thin, the place to say so is in their briefs on whether that burden was met.
The briefing itself is fenced in. The briefs can address two things only: how much weight the GAO report should get, and whether the gaps it found are serious enough to affect this specific rescheduling proposal. Parties cannot file responses to each other's briefs, and the order tells them further requests are disfavored.
When will marijuana be rescheduled now?
Not before November 5. The stay ends when briefing closes that day, and the judge then owes a recommended decision with no deadline attached. That recommendation goes to the DEA Administrator, who makes the final call, so a Schedule III rule covering all marijuana is still several steps away.
The timing also rules out any recommendation before the November 3 election. A separate fight continues in the D.C. Circuit, where consolidated petitions challenge the April 2026 order that moved FDA-approved marijuana products and state-licensed medical marijuana into Schedule III. That court refused to pause the April order on September 9, so it stays in force while the challenges are briefed.
Does any of this change the edibles you can buy?
No. State-licensed medical marijuana products have sat in Schedule III since the April 2026 order, and that order stays in force while the D.C. Circuit hears the challenges to it. Adult-use dispensary edibles remain Schedule I federally until the broader proceeding ends, and nothing on a dispensary shelf changes this week.
When full rescheduling does arrive, the first thing it moves is the federal 280E tax penalty on licensed operators. That is a margin story for dispensaries well before it becomes a price story for you, and it leaves state rules on serving size and package limits exactly where they are.
How does the rescheduling calendar line up with the hemp ban?
Awkwardly. Rescheduling briefs close November 5. Cannabinoids the plant cannot produce lose hemp status November 12. The rest of Section 781, including the 0.4mg per-container cap, takes effect December 11, the same day current government funding runs out.
The two federal tracks pull in opposite directions. One firms up the legal footing of licensed marijuana, and the other closes the side door that hemp gummies have used since 2018. If you buy edibles in a state without dispensaries, the second one reaches you first, and the December 11 checker will tell you whether a specific product survives it. The full date-by-date record lives on the hemp ban tracker.
Replies close November 5, and once they do, the next document in this case is the recommendation itself.